NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for hyperthermia therapy


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
BSD Medical Corporation Reports FDA Review of BSD-2000 Hyperthermia System Continues
2009 OCT 5 ... Humanitarian Device Exemption (HDE) marketing submission for the Company's BSD-2000 Hyperthermia System. On May 15, 2009, the FDA granted Humanitarian Use Device (HUD) ... for the Company's BSD-2000 Hyperthermia System for use in conjunction with radiation therapy for the treatment of cervical carcinoma patients who are ineligible for chemotherapy. ...
Subject: BSD Medical Corp.
Price: $3.00
*
BSD Medical Corporation Sells Hyperthermia System to University of California, San Francisco Medical Center
2009 OCT 12 ... systems internationally. These domestic sales are further evidence of the growing use of hyperthermia therapy in the United States. About UCSF UCSF is a world leader in health care, known for ...
Subject: BSD Medical Corporation
Price: $3.00
*
BSD Medical Reports Hyperthermia Therapy Contributes to Improved Survival Rate for Bladder Cancer Patients
2009 NOV 16 ... in overall survival, tumor response rates, and local tumor control from the addition of hyperthermia therapy, delivered using the BSD-2000 Hyperthermia System, to the standard treatment regimen for ...
Subject: BSD Medical Corporation
Price: $3.00
*
BSD Medical Reports News Briefing at Europe's Largest Cancer Congress: Hyperthermia and Chemotherapy Treatment Prolongs Survival of Sarcoma Cancer Patients
2009 OCT 5 ... 20 to 24, 2009, in Berlin, Germany. A Phase III study, which utilized the BSD-2000 Hyperthermia System, demonstrated that patients with high risk soft-tissue sarcomas were 30% more ... to be alive and cancer free almost three years after starting treatment if targeted heat therapy (hyperthermia) was added to their chemotherapy treatment. The press ...
Subject: BSD Medical Corporation
Price: $3.00
*
Celsion and Yakult Honsha Announce Treatment of First Patient in Japan in Celsion's Global Phase III ThermoDox(R) Trial for Primary Liver Cancer
2009 NOV 9 ... in the treatment of primary liver cancer. About ThermoDox ThermoDox in combination with hyperthermia has the potential to provide local tumor control and improve quality of life. ThermoDox ... tumors. There are few non-surgical therapeutic treatment options available as radiation therapy and chemotherapy are largely ineffective in the treatment of primary liver cancer. About ...
Subject: Celsion Corporation
Price: $3.00
*
Celsion Reports Third Quarter 2009 Financial Results and Business Update
2009 NOV 23 ... in the treatment of primary liver cancer. About ThermoDox ThermoDox in combination with hyperthermia has the potential to provide local tumor control and improve quality of life. ThermoDox ... tumors. There are few non-surgical therapeutic treatment options available as radiation therapy and chemotherapy are largely ineffective in the treatment of primary liver cancer. About ...
Subject: Celsion Corporation
Price: $3.00
*
Celsion's Global Phase III ThermoDox(R) Trial Approved by SFDA in China
2009 NOV 1 ... in the treatment of primary liver cancer. About ThermoDox ThermoDox in combination with hyperthermia has the potential to provide local tumor control and improve quality of life. ThermoDox ... tumors. There are few non-surgical therapeutic treatment options available as radiation therapy and chemotherapy are largely ineffective in the treatment of primary liver cancer. About ...
Subject: Celsion Corporation
Price: $3.00
*
Findings from A. Bakshandehbath and co-authors provide new insights into pancreatic cancer
2009 OCT 12 ... clinical studies using combination chemotherapies that include 41.8 degrees C whole-body hyperthermia for pancreatic adenocarcinoma." "DAN-G pancreatic carcinoma cells were ... of 43 degrees C led to increased hyperthermic damage. Clinical data showed that a therapy of whole-body hyperthermia at 41.8 degrees C with gemcitabine and carboplatin was well ...
Subject: Pancreatic Cancer
Price: $3.00
*
Investigator Meetings Completed in Japan and China for Celsion's Global Phase III ThermoDox(R) Trial for Primary Liver Cancer
2009 NOV 2 ... of patients with non-resectable HCC. About ThermoDox ThermoDox in combination with hyperthermia has the potential to provide local tumor control and improve quality of life. ThermoDox ... tumors. There are few non-surgical therapeutic treatment options available as radiation therapy and chemotherapy are largely ineffective in the treatment of primary liver cancer. ...
Subject: Celsion Corporation
Price: $3.00
*
JHP Pharmaceuticals Introduces a Dantrium IV dantrolene sodium for injection, Rapidly Mixing at 20 Seconds
2009 OCT 12 ... which is 4 times faster than before, saving valuable time and effort during a malignant hyperthermia (MH) emergency. Dantrium® IV, the rapidly mixing product, has the ... for the patient's condition. Administration of Dantrium® IV is one component of therapy and should not be considered a substitute for these measures. Even when properly ...
Subject: JHP Pharmaceuticals, Llc
Price: $3.00
*
New cancer research from Y. Yamada and colleagues discussed
2009 OCT 5 ... Japan, "We evaluated the efficacy and safety of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced metastatic transitional cell carcinoma of the ... Drug Event, Adverse Drug Reaction, Biotechnology, Chemotherapy, Drug Development, Drug Therapy, Drugs, Oncology, Pharmaceuticals, Pharmacology, Therapies, Therapy, Transitional Cell ...
Subject: Cancer
Price: $3.00
*
New data from O. Nativ et al illuminate research in bladder cancer
2009 NOV 1 ... bacillus Calmette-Guerin treatments. We evaluated the efficacy of combined bladder wall hyperthermia and intravesical mitomycin C instillation (thermo-chemotherapy) in cases of recurrence ... wrote O. Nativ and colleagues. The researchers concluded: "Maintenance therapy is important and improves the outcome." Nativ and colleagues published ...
Subject: Bladder Cancer
Price: $3.00
*
Philips and Celsion Advance Development of ThermoDox(R) and MR-Guided HIFU
2009 OCT 5 ... at the Philips conference booth. About ThermoDox® ThermoDox in combination with hyperthermia has the potential to provide local tumor control and improve quality of life. ThermoDox ... MR-HIFU (Magnetic Resonance guided High Intensity Focused Ultrasound) as a combination therapy to non-invasively treat difficult cancers has successfully completed the feasibility ...
Subject: Celsion Corporation and Royal Philips Electronics
Price: $3.00
*
Reports summarize vascular endothelial growth factor research from B. Cohen and co-authors
2009 NOV 16 ... report here that VEGF-C expression is regulated by microenvironmental stress including hyperthermia and oxidative stress," investigators in Rehovot, Israel report. ... of stress-induced lymphangiogenesis and LEDGF as a potential target for antimetastatic therapy." Cohen and colleagues published their study in Neoplasia (Transcriptional ...
Subject: Vascular Endothelial Growth Factor
Price: $3.00
*
Scientists at Nova Southeastern University, College of Pharmacy target glioma
2009 NOV 9 ... A report, 'Mild hyperthermia as a potential mechanism to locally enhance cell growth kinetics,' is newly published ... United States, Fort Lauderdale, Drug Development, Glioma, Oncology, Pharmaceuticals, Therapy, Treatment. This article was prepared by Biotech Business Week editors from ...
Subject: Glioma
Price: $3.00
*
Studies from University of Miami provide new data on hypothermia
2009 NOV 1 ... According to recent research from the United States, "Hyperthermia is common following traumatic brain injury (TBI) and has been associated with poor ... with poor neurologic outcome, and hypothermia has emerged as a potentially effective therapy for TBI, although its mechanism is still unclear. In this study we investigated the ...
Subject: Hypothermia
Price: $3.00
*
Studies from University of Texas add new findings in the area of proteomics
2009 OCT 5 ... "The healing effect of therapeutic hyperthermia induced by widely available heat wrap products is understood to be based on concomitant ... States, Austin, Biomechanical Engineering, Protein Expression, Proteins, Proteomics, Therapy, Treatment, University of Texas. This article was prepared by Biotech ...
Subject: Proteomics
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login